Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:267-274
Published online before print December 24, 2007, doi: 10.1161/HYPERTENSIONAHA.107.097865
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/2/267    most recent
HYPERTENSIONAHA.107.097865v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuchs, S.
Right arrow Articles by Bernstein, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuchs, S.
Right arrow Articles by Bernstein, K. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow ACE/Angiotension receptors

(Hypertension. 2008;51:267.)
© 2008 American Heart Association, Inc.


Original Articles

Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo

Sebastien Fuchs; Hong D. Xiao; Christine Hubert; Annie Michaud; Duncan J. Campbell; Jonathan W. Adams; Mario R. Capecchi; Pierre Corvol; Kenneth E. Bernstein

From the Department of Pathology and Laboratory Medicine (S.F., H.D.X., J.W.A., K.E.B.), Emory University School of Medicine, Atlanta, Ga; Institut National de la Sante et de la Recherché Médicale (C.H., A.M., P.C.), Unité 833, Angiogénèse Embryonnaire et Pathologique, Collège de France, Paris, France; St Vincent’s Institute of Medical Research and the Department of Medicine (D.J.C.), University of Melbourne, St Vincent’s Hospital, Fitzroy, Victoria, Australia; and the Howard Hughes Medical Institute (M.R.C.), Eccles Institute of Human Genetics, University of Utah, Salt Lake City.

Correspondence to Sebastien Fuchs, 101 Woodruff Circle, Emory University, Atlanta, GA 30322. E-mail sfuchs{at}emory.edu

Angiotensin-converting enzyme (ACE) plays a central role in the production of the vasoconstrictor angiotensin II. ACE is a single polypeptide, but it contains 2 homologous and independent catalytic domains, each of which binds zinc. To understand the in vivo role of these 2 domains, we used gene targeting to create mice with point mutations in the ACE C-domain zinc-binding motif. Such mice, termed ACE13/13, produce a full-length ACE protein with tissue expression identical to wild-type mice. Analysis of ACE13/13 mice showed that they produce ACE having only N-domain catalytic activity, as determined by the hydrolysis of domain specific substrates and by chloride sensitivity. ACE13/13 mice have blood pressure and blood angiotensin II levels similar to wild-type mice. However, plasma renin concentration is increased 2.6-fold and blood angiotensin I levels are increased 7.5-fold. Bradykinin peptide levels are not different from wild-type levels. ACE13/13 mice have a reduced increase of blood pressure after intravenous infusion of angiotensin I. ACE13/13 mice have a normal renal structure, but they are not able to concentrate urine after dehydration as effectively as wild-type mice. This study shows that the C-domain of ACE is the predominant site of angiotensin I cleavage in vivo. Although mice lacking C-domain activity have normal physiology under laboratory conditions, they respond less well to the stress of dehydration.


Key Words: angiotensin-converting enzyme • angiotensin • blood pressure • male infertility • catalytic sites • bradykinin • genetic mice model




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Zou, T. Maeda, A. Watanabe, J. Liu, S. Liu, R. Oba, Y.-i. Satoh, H. Komano, and M. Michikawa
A{beta}42-to-A{beta}40- and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
J. Biol. Chem., November 13, 2009; 284(46): 31914 - 31920.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Liu, C. O. C. Bellamy, M. A. Bailey, L. J. Mullins, D. R. Dunbar, C. J. Kenyon, G. Brooker, S. Kantachuvesiri, K. Maratou, A. Ashek, et al.
Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage
J. Biol. Chem., June 5, 2009; 284(23): 15564 - 15572.
[Abstract] [Full Text] [PDF]